BDX
NYSE:BDXB
BD
- Stock
169.54
−18.13%
−25.42
news - Aug 12, 2025 - 18:30
US Surgical Instrument Tracking Market Size/Share
The US Surgical Instrument Tracking Market is projected to grow from USD 74.48 million in 2024 to USD 226.61 million by 2034, driven by rising surgical volumes, chronic disease prevalence, and the need for improved patient safety and operational efficiency. Key factors include reduced risk of retained surgical instruments, streamlined workflows, and compliance with U.S. FDA’s UDI regulations. Market growth is supported by innovations in barcode and RFID technologies, with segmentation by technology, application, end-use, and region. Major players include Vizinex (HID Global Corporation), Fortive Corporation, Becton Dickinson and Company (BD), Steris, Integra LifeSciences Corporation, Censis, Surlogs, Stryker, Medtronic, B. Braun SE, Olympus Corporation, Case Medical, Scanlan International, Inc., and Securitas Healthcare LLC. Recent developments include Mobile Aspects launching SurgiCart, HID Global acquiring GuardRFID, and BD introducing a robotic tracking system for laboratory specimen processing. The report includes a SWOT analysis highlighting strengths in technological innovation and regulatory compliance, weaknesses in integration and system vulnerabilities, opportunities in AI adoption and specialty customization, and threats from cyberattacks and price competition.
globenewswire.comnews - Aug 12, 2025 - 17:37
Hernia Mesh Lawsuits: Q&A with Attorney Brett Vaughn
Thousands of individuals are suing hernia mesh manufacturers over defective products that cause serious injuries such as organ damage, adhesions, chronic pain, infection, sepsis, bowel obstruction, and even death. In 2024, Becton Dickinson offered to settle 38,000 cases involving its subsidiary C.R. Bard, with an estimated settlement value of $1.7 billion. The litigation includes over 26,000 lawsuits consolidated into two multidistrict litigations (MDLs) involving companies such as Covidien/Medtronic, Bard/Davol, Ethicon/Johnson & Johnson, Gore, Atrium, and LifeCell. Despite settlements, manufacturers continue to sell the same products. Injuries vary widely and can lead to significant physical, mental, and financial strain. Jury awards range from $250,000 to $4,800,000, and plaintiffs are advised to consult experienced attorneys and obtain medical records, including implant identification records, to strengthen claims.
drugwatch.comnews - Aug 12, 2025 - 16:53
In Vitro Diagnostics Market Size to Exceed USD 132.18 Bn by 2034
The global in vitro diagnostics (IVD) market is projected to exceed USD 132.18 billion by 2034, growing from USD 104.01 billion in 2025 at a compound annual growth rate (CAGR) of 2.30%. Growth is driven by rising chronic disease prevalence, demand for early disease detection, and advancements in molecular testing technologies. North America holds a 42% revenue share in 2024, with the Asia Pacific region showing significant growth potential. The reagents segment dominates with a 66.07% market share in 2024, while molecular diagnostics account for 33.06% of the market. Key applications include infectious diseases (52.53% share) and oncology, with hospitals being the largest end-user segment. Innovations such as AI-integrated diagnostics, portable PCR platforms, and smartphone-compatible devices are enhancing accuracy and accessibility, particularly in point-of-care and home care settings. Major players include Abbott, BD, Thermo Fisher, Alere, Roche, Beckman Coulter, Bio-Rad, and Sysmex. Recent product launches include InBios' ELISA kit for strongyloidiasis, GenWorks Health's tests for malaria and dengue, and NeoDx Biotech's HLA-B27 RT-PCR kit for autoimmune disorders.
globenewswire.comnews - Aug 12, 2025 - 14:43
US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD
The United States Durable Medical Equipment (DME) market is projected to grow at a compound annual growth rate (CAGR) of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033. Growth is driven by an aging population, rising chronic disease prevalence, and increased demand for home healthcare. Key segments include personal mobility devices (such as wheelchairs, scooters, walkers) and monitoring/therapeutic equipment (like glucose monitors, oxygen devices, and nebulizers). Major players include Invacare, Abbott, Medtronic, Inogen, Thermo Fisher Scientific, Baxter, B. Braun, Boston Scientific, and BD. California and New York are highlighted as key markets due to demographic trends and healthcare infrastructure. Technological advances such as smart devices, telehealth integration, and portable medical solutions are enhancing patient independence and therapy outcomes. However, high equipment costs, complex reimbursement processes, and strict regulatory compliance with FDA, CMS, and state agencies present significant challenges for manufacturers and new entrants.
finance.yahoo.comnews - Aug 12, 2025 - 10:42
US Durable Medical Equipment Market Forecast to Grow at 5.03% CAGR
The United States Durable Medical Equipment (DME) market is projected to grow at a compound annual growth rate (CAGR) of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033. Growth is driven by an aging population, rising chronic disease prevalence, increased demand for home healthcare, and technological advancements in devices such as smart wheelchairs, glucose monitors, and telehealth-integrated equipment. Key market segments include personal mobility devices and monitoring/therapeutic equipment. Major players like Invacare, Abbott, and Medtronic are leading innovation. California and New York are highlighted as key markets due to demographic and healthcare infrastructure factors. However, high costs, complex reimbursement processes, and strict regulatory requirements from the FDA, CMS, and state agencies present significant challenges for both patients and new entrants.
globenewswire.comDescription
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral ca...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus